title: New targets for the treatment of advanced non-small cell lung cancer.
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, University of Texas, M.D. Anderson Cancer Center, P.O. Box 432, Houston, TX 77030, USA.
authors.forename: Erminia
authors.initials: E
authors.lastname: Massarelli
authors.forename: Amir
authors.initials: A
authors.lastname: Onn
authors.forename: Ralph
authors.initials: R
authors.lastname: Zinner
authors.forename: Fadlo R
authors.initials: FR
authors.lastname: Khuri
authors.forename: Edward S
authors.initials: ES
authors.lastname: Kim
authors.forename: Roy S
authors.initials: RS
authors.lastname: Herbst
mesh_terms: D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D003131:Combined Modality Therapy; D051231:Farnesyltranstransferase; D015316:Genetic Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase